IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 137 filers reported holding IMMUNOGEN INC in Q1 2017. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $451,000 | +44.6% | 166,469 | +156.1% | 0.03% | +62.5% |
Q4 2018 | $312,000 | -42.8% | 65,000 | -75.7% | 0.02% | +14.3% |
Q4 2016 | $545,000 | +343.1% | 267,300 | +482.4% | 0.01% | +250.0% |
Q3 2016 | $123,000 | -79.5% | 45,900 | -76.5% | 0.00% | -85.7% |
Q2 2016 | $601,000 | +241.5% | 195,400 | +844.0% | 0.03% | +211.1% |
Q1 2016 | $176,000 | -36.2% | 20,700 | -28.1% | 0.01% | -57.1% |
Q3 2015 | $276,000 | -55.6% | 28,800 | -33.3% | 0.02% | -77.7% |
Q2 2015 | $621,000 | +469.7% | 43,200 | +254.1% | 0.09% | +840.0% |
Q1 2015 | $109,000 | – | 12,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |